NCT04477863 Follow-up With Preimplantation Genetic Testing Patients
| NCT ID | NCT04477863 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Genomic Prediction Inc. |
| Condition | Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-07-11 |
| Primary Completion | 2050-07-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-07-11 with a primary completion date of 2050-07-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.
Eligibility Criteria
Inclusion Criteria: * Patients indicating willingness to participate in research during informed consent to perform PGT Exclusion Criteria: * Patients who opted out of participating in research during informed consent to perform PGT
Contact & Investigator
Nathan R Treff, PhD
PRINCIPAL INVESTIGATOR
Genomic Prediction
Frequently Asked Questions
Who can join the NCT04477863 clinical trial?
This trial is open to participants of all sexes, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04477863 currently recruiting?
Yes, NCT04477863 is actively recruiting participants. Contact the research team at Talia@genomicprediction.com for enrollment information.
Where is the NCT04477863 trial being conducted?
This trial is being conducted at North Brunswick, United States.
Who is sponsoring the NCT04477863 clinical trial?
NCT04477863 is sponsored by Genomic Prediction Inc.. The principal investigator is Nathan R Treff, PhD at Genomic Prediction. The trial plans to enroll 10,000 participants.